NEW YORK, Sept. 18 /PRNewswire/ -- iiBIG is pleased to announce the never- before assembly of Global Cancer Experts at the 2008 Global Cancer Congress: Lighting the Onco-Pipeline -- Innovations in Stem Cell, Biomarker, Chemistry & Novel Therapeutic R&D, January 28-29, 2008 in Tampa, Florida. iiBIG is particularly pleased to join forces with our Florida affiliates from University of South Florida, University of Florida, Shands Cancer Center, Scripps Florida, and the other Florida cancer and academic institutes along with our nationally recognized distinguished faculty at this cutting-edge event.
This event will be the torchbearer to the most significant advances in cancer research, new therapies and novel approaches in the "War against Cancer". The program features a 2-track forum, with over 30 speakers, comprising plenary keynotes, lectures, panel sessions, roundtable discussions, interactive conversations with faculty and delegates, and actionable networking opportunities with leaders in various aspects of cancer research.
Distinguished Executive Speaking Faculty:
David L. Keefe, M.D.
James M. Ingram Professor and Chairman of the Department of Obstetrics and
University of South Florida
George Church, Ph.D.
Director of the Center for Computational Genetics, Director of the
Department of Genetics
Harvard-MIT Division of Health Sciences & Technology and Harvard Medical
School, Harvard University
William G. Thilly, Sc.D.
Professor of Biological Engineering
David J. Newman, Phil Sc.,
Chief, Natural Products Branch
National Cancer Institute (NCI)-FCRDC
James L. Sherley, M.D., Ph.D.
Regenerative Biology and Cancer Programs
Boston Biomedical Research Institute
Edward Scott, Ph.D.
Director of the UF Program in Stem Cell Biology and Regenerative Medicine
University of Florida
Gary D. Smith, Ph.D.,
Associate Professor, Departments of OB/GYN, Physiology, and Urology
Director: Reproductive Sciences Program, University of Michigan
James D. McChesney, Ph.D.,
CSO, Natural Products Chemistry
Tapestry Pharmaceuticals, Inc.
Tomi Sawyer, Ph.D.,
Senior Director, Department of Chemical Sciences
Pfizer Global R&D
Director Genomic Research Division
Dalia Cohen, Ph.D.
Executive Vice President, Head of Global Research and Development
Rosetta Genomics, Ltd.
Gregg B. Fields, Ph.D.,
Professor and Chair, Department of Chemistry & Biochemistry
Florida Atlantic University
Chris Liang, Ph.D.
Scientific Director I, Translational Research Institute
Marilyn A. Apfel, Ph.D.
Co-founder and President
Julia H. Riley, DVM, MS,
Diplomate American College Veterinary Pathologists, Diplomate American
Board Toxicology, Heads the Biologics Division, Toxicologist
Ahsan Awan, JD, MBA,
Chief Executive Officers
Global CINRG, Inc.
Bernard Munos, Ph.D.,
Advisor, Corporate Strategy
Eli Lilly and Company
President & CEO
CHS Resources LLC
Jean-Claude Bystryn, M.D.
CEO & CSO
President and CEO
BIND Biosciences, Inc., latest Robert Langer, Ph.D. - MIT, Nanotechnology
Christopher Milne, D.V.M., M.P.H., J.D.
Tufts Center for Drug Development
Mark Newman, Ph.D.
Senior Vice President, Global Research and Development Laboratories
Some of the conference topics to be addressed (but are not limited to) include:
-- Integrative BioPharma Oncogenomics Standardizing Genetic Analysis
-- Drug Discovery Breakthroughs-Promising Compounds
-- Stem Cell Biology & Genetic Integrity
-- Interplay between Cancer & Stem Cells
-- Proteomic Biomarkers - Molecular Diagnostics: Earlier Detection and
-- Therapeutic Vaccines Advancements
-- Multi-Drug Interaction - Drug Safety
-- Cancer Susceptibility, Resistance, and Systemic Changes
-- New Drugs Showing Real Promise
-- C-Team - Business Collaboration & Alliances between academia,
government, industry, foundations, regulatory, and private investment
resources - The Real Scenarios!
-- Biotech Showcase: Visit with 5 exciting young biotechnology companies*
in the cancer marketplace - The Real Light Makers
SPEAKING OPPORTUNITIES: Topic abstracts and speaker profiles will be accepted for consideration.
For more information, please contact Shelley Amster, VP, Pharmaceutical & Life Sciences Conferences, iiBIG, at 978-371-5901 or Shelleya@iibig.com.
SPONSORSHIP OPPORTUNITIES: For information on available sponsorship and exhibiting opportunities, please contact Kellie Swanstrom, VP Business Development, iiBIG, at 973-571-0867 or email@example.com.
FOR CONFERENCE UPDATES AND REGISTRATION INFORMATION:
Please visit: http://www.iibig.com/P0801
Copyright©2007 PR Newswire.
All rights reserved